Petrou MJ - Search Results

1

Injuries among judokas during competition.

Green CM, Petrou MJ, Fogarty-Hover ML, Rolf CG. Green CM, et al. Among authors: petrou mj. Scand J Med Sci Sports. 2007 Jun;17(3):205-10. doi: 10.1111/j.1600-0838.2006.00552.x. Scand J Med Sci Sports. 2007. PMID: 17501865

2

The impact of nutrition education on nutrition knowledge and adherence to the Mediterranean Diet in adolescent competitive swimmers.

Philippou E, Middleton N, Pistos C, Andreou E, Petrou M. Philippou E, et al. J Sci Med Sport. 2017 Apr;20(4):328-332. doi: 10.1016/j.jsams.2016.08.023. Epub 2016 Sep 16. J Sci Med Sport. 2017. PMID: 27692575

3

Comment on "Recreational Athletes' Use of Performance‑Enhancing Substances: Results from the First European Randomized Response Technique Survey".

Petrou M, Lazuras L. Petrou M, et al. Sports Med Open. 2023 May 29;9(1):36. doi: 10.1186/s40798-023-00581-9. Sports Med Open. 2023. PMID: 37247047 Free PMC article. No abstract available.

4

Determination of salmeterol, α-hydroxysalmeterol and fluticasone propionate in human urine and plasma for doping control using UHPLC-QTOF-MS.

Sakellariou P, Petrou M, Lyris E, Tsivou M, Fragkaki A, Kiousi P, Angelis YS, Pistos C. Sakellariou P, et al. Biomed Chromatogr. 2021 Aug;35(8):e5114. doi: 10.1002/bmc.5114. Epub 2021 Apr 11. Biomed Chromatogr. 2021. PMID: 33720401

5

Re: Kuipers H, Ruijsch van Dugteren G. Letter to the editors - the prohibited list and cheating in sport. Int J Sports Med 2006; 27: 80 - 82.

Petrou MJ. Petrou MJ. Int J Sports Med. 2006 Jan;27(1):83-4. doi: 10.1055/s-2005-873070. Int J Sports Med. 2006. PMID: 16388448 No abstract available.

6

Comprehensive plasma-screening for known and unknown substances in doping controls.

Thomas A, Guddat S, Kohler M, Krug O, Schänzer W, Petrou M, Thevis M. Thomas A, et al. Rapid Commun Mass Spectrom. 2010 Apr 30;24(8):1124-32. doi: 10.1002/rcm.4492. Rapid Commun Mass Spectrom. 2010. PMID: 20301105

7

Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry.

Thomas A, Höppner S, Geyer H, Schänzer W, Petrou M, Kwiatkowska D, Pokrywka A, Thevis M. Thomas A, et al. Anal Bioanal Chem. 2011 Aug;401(2):507-16. doi: 10.1007/s00216-011-4702-3. Epub 2011 Feb 6. Anal Bioanal Chem. 2011. PMID: 21298258

8

Quantification of clenbuterol at trace level in human urine by ultra-high pressure liquid chromatography-tandem mass spectrometry.

Nicoli R, Petrou M, Badoud F, Dvorak J, Saugy M, Baume N. Nicoli R, et al. J Chromatogr A. 2013 May 31;1292:142-50. doi: 10.1016/j.chroma.2012.12.008. Epub 2012 Dec 19. J Chromatogr A. 2013. PMID: 23294994

9

Human in vivo metabolism study of LGD-4033.

Fragkaki AG, Sakellariou P, Kiousi P, Kioukia-Fougia N, Tsivou M, Petrou M, Angelis Y. Fragkaki AG, et al. Drug Test Anal. 2018 Nov;10(11-12):1635-1645. doi: 10.1002/dta.2512. Epub 2018 Nov 8. Drug Test Anal. 2018. PMID: 30255601

10

Human in vivo metabolism study of LGD-4033.

Fragkaki AG, Sakellariou P, Kiousi P, Kioukia-Fougia N, Tsivou M, Petrou M, Angelis Y. Fragkaki AG, et al. Drug Test Anal. 2020 Jan;12(1):164. doi: 10.1002/dta.2700. Epub 2019 Nov 17. Drug Test Anal. 2020. PMID: 31984662 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

14 results

Search Page